Related references
Note: Only part of the references are listed.Small silencing RNAs: State-of-the-art
Dirk Grimm
ADVANCED DRUG DELIVERY REVIEWS (2009)
Concepts in In Vivo siRNA Delivery for Cancer Therapy
Christopher S. Gondi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
Paula Hauck et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells
Lin Jie Zhang et al.
ANTI-CANCER DRUGS (2008)
Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
M. Rippo et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Resistance mechanisms to cancer chemotherapy
Kelly Marie Redmond et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts
James E. Littlejohn et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Apoptosis supercedes necrosis in mitochondrial DNA-depleted Jurkat cells by cleavage of receptor-interacting protein and inhibition of lysosomal cathepsin
Tsutomu Sato et al.
JOURNAL OF IMMUNOLOGY (2008)
Recent advances in the treatment of malignant pleural mesothelioma
Suresh S. Ramalingam et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Bcl-2 family proteins and cancer
K. W. Yip et al.
ONCOGENE (2008)
Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Ramzi Mohammad et al.
Recent Patents on Anti-Cancer Drug Discovery (2008)
Diagnosing and exploiting cancer's addiction to blocks in apoptosis
Anthony G. Letai
NATURE REVIEWS CANCER (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma
Xiaobo Cao et al.
CANCER BIOLOGY & THERAPY (2007)
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
Stephen K. Tahir et al.
CANCER RESEARCH (2007)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
Shuang Chen et al.
CANCER RESEARCH (2007)
Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells
Cheng Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
Wen-Shuz Yeow et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
BCL-2 in the crosshairs: tipping the balance of life and death
L. D. Walensky
CELL DEATH AND DIFFERENTIATION (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
M. Jiang et al.
ONCOGENE (2006)
Expression of Bcl-2 family members in malignant pleural mesothelioma
Sara L. O'Kane et al.
ACTA ONCOLOGICA (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Life in the balance: how BH3-only proteins induce apoptosis
SN Willis et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells
LX Song et al.
CANCER BIOLOGY & THERAPY (2005)
The role of Bcl-2 family members in tumorigenesis
V Kirkin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-XL- and PKB/AKT-independent fashion
D Gramaglia et al.
CELL DEATH AND DIFFERENTIATION (2004)
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development
DA Fennell et al.
LANCET ONCOLOGY (2004)
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
M Herrant et al.
ONCOGENE (2004)
Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment
S Hopkins-Donaldson et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product
WR Smythe et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma
GJ Gordon et al.
CARCINOGENESIS (2002)
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing
Y Kabeya et al.
EMBO JOURNAL (2000)
Share Paper
